Glycocalyx dysfunction and syndecan-1 shedding have been described in a variety of clinical pathophysiologic processes, including sepsis [13], hemorrhagic shock [14], atherosclerosis [15], acute coronary syndrome [16], renal disease [17], diabetes [10], and hypervolemia [18]. Here, SDC1 is linked to Sepsis.